Guardant Health Inc (NASDAQ:GH) has a beta value of 1.13 and has seen 0.84 million shares traded in the recent trading session. The company, currently valued at $3.84B, closed the recent trade at $31.40 per share which meant it gained $0.9 on the day or 2.95% during that session. The GH stock price is -30.76% off its 52-week high price of $41.06 and 49.65% above the 52-week low of $15.81. The 3-month trading volume is 2.40 million shares.
Guardant Health Inc (NASDAQ:GH) trade information
Sporting 2.95% in the green today, the stock has traded in the green over the last five days, when the GH stock price touched $31.40 or saw a rise of 1.66%. Year-to-date, Guardant Health Inc shares have moved 16.08%, while the 5-day performance has seen it change 0.67%. Over the past 30 days, the shares of Guardant Health Inc (NASDAQ:GH) have changed 40.37%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guardant Health Inc (GH) estimates and forecasts
Figures show that Guardant Health Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 21.99% over the past 6 months, with this year growth rate of 49.30%, compared to 15.40% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -8.88% over the past 5 years. Earnings growth for 2024 is a modest 25.79% while over the next 5 years, the company’s earnings are expected to increase by 29.20%.
GH Dividends
Guardant Health Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
